Age-related changes in brain extracellular space affect processing of amyloid-β peptides in alzheimer's disease

Journal of Alzheimer's Disease

Volumn 35, Issue 1, 2013, Pages 1-6

  Bondareff, William ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Aging; Alzheimer's disease; brain; extracellular matrix; extracellular space

Indexed keywords

AGRIN; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; PROTEOCHONDROITIN SULFATE; PROTEOGLYCAN; PROTEOHEPARAN SULFATE;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; CEREBROSPINAL FLUID; COGNITION; EXTRACELLULAR SPACE; HUMAN; IMMUNOELECTRON MICROSCOPY; IMMUNOREACTIVITY; INTERSTITIAL FLUID; MOLECULAR INTERACTION; NERVE CELL NETWORK; NEUROFIBRILLARY TANGLE; NONHUMAN; OUTER MEMBRANE; PRIORITY JOURNAL; REVIEW; SENILE PLAQUE; SPIN LABELING; SYNCYTIUM;

EID: 84876373799     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-122305     Document Type: Review

References (44)

1. Sperling RA, Aisen PS, Beckett LA, Craft S, FaganAM, Iwatsuko T, Jack CR Jr, Kay J, Montine TJ, Park DC, Reiman EM, Rowe CR, Siemers E, Stein Y, Jaffe, Carrillo MC, Thies B, Morrison-Bogorad M, Wagster MV, Phelps CH (2012) Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging- Alzheimers Association work groups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7, 280-292.
2. Selkoe DJ (2012) Preventing Alzheimer's disease. Science 337, 1488-1492.
3. Bondareff W (1965) The extracellular compartment of the cerebral cortex. Anat Rec 152, 119-129.
4. BondareffW, Pysh JJ (1968) Distribution of the extracellular space during postnatal maturation of rat cerebral cortex. Anat Rec 160, 773-780.
5. Van Harreveld A, Crowell J, Malhotra SK (1965) A study of extracellular space in central nervous tissue by freezesubstitution. J Cell Biol 25, 117-137.
6. Nicholson C, Sykova E (1998) Extracellular space structure revealed by diffusion analysis. Trends Neurosci 21, 207-215. (Pubitemid 28191815)
7. Sykova E, Nicholson C (2008) Diffusion in brain extracellular space. Physiol Rev 88, 1277-1340.
8. Gersh I, CatchpoleHR(1960) The nature of ground substance of connective tissue. Perspect Biol Med 3, 282-319.
9. Donahue JE, Berzin TM, Rafii MS, Glass DJ, Yancopoulos GD, Fallon JR, Stopa EG (1999) Agrin in Alzheimer's disease: Altered parenchyma and abnormal distribution within microvasculature and brain parenchyma. Proc Natl Acad Sci U S A 96, 6468-6472. (Pubitemid 29256689)
10. Bignami A, Hosley M, Dahl D (1993) Hyaluronic acid and hyaluronic acid-binding proteins in brain extracellular matrix. Anat Embryol 188, 419-433. (Pubitemid 24000108)
11. Aquino DA, Margolis RU, Margolis RK (1984) Immunocytochemical localization of a chondroitin sulfate proteoglycan in nervous tissue II. Studies in developing brain. J Cell Biol 99, 1130-1139. (Pubitemid 14043371)
12. Lander AD, Fujii DK, Reichardt LF (1982) Characterization of a factor that promotes neurite outgrowth: Evidence linking activity to a heparin sulfate proteoglycan. J Cell Biol 94, 574-585. (Pubitemid 13241189)
13. Perrimon N, BernfieldM(2001) Cellular functions of proteoglycans - an overview. Semin Cell Develop Biol 12, 65-67. (Pubitemid 35425489)
14. Wiese S, Karus M, Faissner A (2012) Astrocytes as a source for extracellular matrix molecules and cytokines. Front Pharmacol 20, 120-132.
15. Perrimon N, Bernfield M (2000) Specificities of heparin sulfate proteoglycans in developmental processes. Nature 404, 725-728. (Pubitemid 30212391)
16. Frischnecht R, Seidenbacher CI (2008) The crosstalk of hyaluran based extracellular matrix and synapses. Neuron Glia Biol 4, 249-257.
17. Wight FN, Toole BP, Hascall VC (2011) Hyaluronan and the aggregating proteoglycans. In The Extracellular Matrix: An Overview, Series: Biology of Extracellular Matrix, Mecham RP, Ed. Springer-Verlag, Berlin Heidelberg, pp. 147-195.
18. Cotman SL, Halfter W, Cole GJ (2000) Agrin binds to beta-amyloid (Aβ), accelerates Aβ fibril formation, and is localized to Aβ deposits in Alzheimer's disease brain. Mol Cell Neurosci 15, 183-198. (Pubitemid 30109121)
19. Thorne RG, Nicholson C (2006) In vivo diffusion analysis with quantum dots and dextrans predicts the width of brain extracellular space. Proc Natl Acad Sci U S A 103, 5567-5572.
20. Iliff JJ,Wang M, Liao Y, Plogg BA, PengW, Gundersen GA, Benveniste H, Vates GE, Deane R, Goldman SA, Nagelhus EA, NedergaardM(2012) A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid-β. Sci Transl Med 4, 147ra111.
21. Mathiisen TM, Lehre KP, Danbolt NC, Ottersen OP (2010) The perivascular astroglial sheath provides a complete covering of the brain microvessels: An electron microscopic 3D reconstruction. Glia 58, 1094-1103.
22. Bateman RJ, Xiong C, Benzinger TL, Fagan AM, Goate A, Fox NC, Marcus DS, Cairns NJ, Xie X, Blazey TM, Holtzman DM, Santacruz A, Buckles V, Oliver A, Moulder K, Aisen PS, Ghetti B, Klunk WE,McDade E, Martins RN, Masters CL, Mayeux R, Ringman JM, Rossor MN, Schofield PR, Sperling RA, Salloway S, Morris JC, Dominantly Inherited Alzheimer Network (2012) Clinical and biomarker changes in dominantly inherited Alzheimer's disease. New Engl J Med 367, 795-804.
23. Haas C, Kaether C, Thinakaran G, Sisodia S (2012) Trafficking and proteolytic process of APP. Cold Spring Harb Perspect Med 2, a006270.
24. Mucke L, Selkoe DJ (2012) Neurotoxicity of amyloid β- protein: Synaptic and network dysfunction. Cold Spring Harb Perspect Med 2, a006338.
25. De Strooper B, Iwatsubo T, Wolfe MS (2012) Presenilins and β-secretase: Structure, function, and role in Alzheimer disease. Cold Spring Harb Perspect Med 2, a006304.
26. Nagele RG, A'Andrea MR, Lee H, Venkataraman V, Wang HY (2003) Astrocytes accumulate Abeta 41 and give rise to astrocytic amyloid plaques in Alzheimer disease brains. Brain Res 97, 197-209. (Pubitemid 36423321)
27. Ariga T, Miyatake T, Yu RK (2010) Role of proteoglycans in the pathogenesis of Alzheimer's disease and related disorders; amyloidogenesis and therapeutic strategies - a review. J Neurosci Res 88, 2303-2315.
28. Frazer PE, Nguyen JT, Chin DT, Kirschner DA (1992) Effects of sulfate ions on Alzheimer beta/A4 peptide assemblies: Implications for amyloid fibril-proteoglycan interactions. J Neurochem 59, 1531-1540.
29. Fralich TJ (2009) Roles of brain proteoglycans and neuroglia in amyloid-beta (Aβ) deposition and clearance in Alzheimer's disease. Columbia University Dissertation, Publication 334838.
30. Chiu C, Miller MC, Caralopoulos IN,Worden MS, Brinker T, Gordon ZN, Johanson CE, Silverberg GD (2012) Temporal course of cerebrospinal fluid dynamics and amyloid accumulation in the aging rat brain from three to thirty months. Fluids Barriers CN 9, 3.
31. May C, Kaye JA, Atack JR, Shapiro MB, Friedland RP, Rapoport SI (1990) Cerebrospinal fluid production is reduced in healthy aging. Neurology 40, 500-503. (Pubitemid 20117538)
32. Chen CP, Chen RL, Preston JE (2012) The influence of ageing in the cerebrospinal fluid concentrations of proteins that are derived from the choroid plexus, brain, and plasma. Exp Gerontol 47, 323-328.
33. Zhang JN, Goodlett DR, Peskind JR, Quinn JF, Zhou Y,Wang Q, Pan C, Yi E, Eng J, Aebersold RH, Montine TJ (2005) Quantitative proteomic analysis of age-related changes in human cerebrospinal fluid. Neurobiol Aging 26, 207-227. (Pubitemid 39610462)
34. Silverberg GD, Mayo M, Saul T, Rubenstein E, McGuire D (2003) Alzheimer's disease, normal-pressure hydrocephalus, and senescent changes in CSF circulatory physiology: A hypothesis. Lancet Neurol 2, 506-511. (Pubitemid 36876108)
35. Shibata M, Yamada S, Kumar SR, Calero M, Bading J, Frangione B, Holtzman DM, Millar CA, Strickland DK, Ghiso J, Zlokovic BV (2000) Clearance of Alzheimer's amyloid-ss (1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J Clin Invest 106, 11489-11499.
36. Tanzi RE, Moir RD, Wagner SL (2004) Clearance of Alzheimer'sAβ peptide: The many roads to perdition. Neuron 43, 605-608. (Pubitemid 39179722)
37. Sagare AP, Bell RD, Zlokovic BV (2012) Neurovascular dysfunction and faulty amyloid β-peptide clearance in Alzheimer disease. Cold Spring Harb Perspect Med 2, pii: a011452.
38. Sykova E,Mazel T, Simonova Z (1998) Diffusion constraints and neuron-glia interaction during aging. Exp Gerontol 33, 837-851. (Pubitemid 29019338)
39. Sykova E, Vonsek I, Antonova T, Mazel T, Meyer-Luehmann M, Jucker M, Hajek M, Ort M, Bures J (2005) Changes in extracellular space size and geometry in APP23 transgenic mice: A model of Alzheimer's disease. Proc Natl Acad Sci U S A 102, 479-484. (Pubitemid 40116792)
40. BondareffW, Narotzky R (1972) Age changes in the neuronal microenvironment. Science 176, 1135-1136.
41. Chen JJ, Rosas HD, Salat DH (2011) Age-associated reductions in cerebral blood flow are independent from regional atrophy. Neuroimage 15, 458-478.
42. Sojkova J, Beason-Held L, Zhou Y, An Y, Kraut MA, Ye W, Ferrucci L, Mathis CA, Klunk WE, Wong DF, Resnick SM (2008) Longitudinal cerebral blood flow and amyloid deposition: An emerging pattern? J Nucl Med 49, 1465-1471.
43. Prusiner SB (2012) A unifying role for prions in neurodegenerative diseases. Science 336, 1511-1513.
44. Lahiri DK (2012) Prions: A piece of the puzzle? Science 337, 1172.